About Tempus AI, Inc.
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
2BB score and signals
Tempus AI, Inc.’s current 2BB score is 60 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 70 | High |
| Momentum | 60 | Improving |
| Financial strength | 32 | Weak |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| CEO | Eric Lefkofsky |
| Headquarters | Chicago, Illinois, United States |
| Founded | 2015 |
| Employees | 3.8K |
| 52-week range | $40.77 – $104.32 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | -0.0241 | — | $460.05M |
| 2026-10-29 | — | -0.08 | — | $414.74M |
| 2026-07-30 | — | -0.1419 | — | $383.54M |
| 2026-05-05 | -0.13 | -0.1935 | $348.12M | $348.88M |
Related companies